edoxaban tosylate
SpainDrugs containing this active substance
-
It is used in adults to prevent the formation of blood clots in the brain and other blood vessels in people with a type of irregular heartbeat (non-valvular atrial fibrillation) and other risk factors. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), helping to prevent their recurrence.
Form: tablets, film-coated
Active substance Dosage edoxaban tosylate 20,205 mg Manufacturer: Daiichi Sankyo Europe Gmbh
-
It is used in adults to prevent the formation of blood clots in the brain and other blood vessels in people with an irregular heart rhythm (non-valvular atrial fibrillation) and other risk factors. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent them from recurring.
Form: tablets, film-coated
Active substance Dosage edoxaban tosylate 40,410 mg Manufacturer: Daiichi Sankyo Europe Gmbh
-
It is used in adults to prevent the formation of blood clots in the brain and other blood vessels in people with an irregular heartbeat called non-valvular atrial fibrillation. It is also used to treat blood clots in the leg veins (deep vein thrombosis) and in the lungs (pulmonary embolism), as well as to prevent them from recurring.
Form: tablets, film-coated
Active substance Dosage edoxaban tosylate 40,410 mg Manufacturer: Daiichi Sankyo Europe Gmbh
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels in people with a type of irregular heartbeat called non-valvular atrial fibrillation and other risk factors. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent their recurrence.
Form: tablets, film-coated
Active substance Dosage edoxaban tosylate 80,820 mg Manufacturer: Daiichi Sankyo Europe Gmbh
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels in people with an irregular heart rhythm called non-valvular atrial fibrillation. It is also used to treat blood clots in the veins of the legs (deep vein thrombosis) and in the lungs (pulmonary embolism), and to prevent them from occurring again.
Form: tablets, film-coated
Active substance Dosage edoxaban tosylate 80,820 mg Manufacturer: Daiichi Sankyo Europe Gmbh